Galectin Therapeutics Inc (GALT): Weighted Average Diluted Shares
63.90M
Year ended 2025-12-31
+2.5%
3-year compound annual growth
+2.3%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 63.90M | +2.6% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | 62.31M | +3.6% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | 60.16M | +1.3% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | 59.39M | +1.5% | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | 58.53M | +2.6% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | 57.03M | n/a | 2022-03-31, From 2020-01-01 |